These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 20845499)

  • 1. Pulmonary outcome prediction for cystic fibrosis patients.
    Kraemer R; Thamrin C
    Pediatr Pulmonol; 2010 Dec; 45(12):1153-5. PubMed ID: 20845499
    [No Abstract]   [Full Text] [Related]  

  • 2. Pacing the marathon: rate of decline of pulmonary function in cystic fibrosis.
    Davis PB
    J Pediatr; 2007 Aug; 151(2):111-3. PubMed ID: 17643757
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary prognosis in cystic fibrosis patients with liver disease.
    Slieker MG; van der Doef HP; Deckers-Kocken JM; van der Ent CK; Houwen RH
    J Pediatr; 2006 Jul; 149(1):144; author reply 144-5. PubMed ID: 16860146
    [No Abstract]   [Full Text] [Related]  

  • 4. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis.
    Robinson TE; Leung AN; Northway WH; Blankenberg FG; Bloch DA; Oehlert JW; Al-Dabbagh H; Hubli S; Moss RB
    J Pediatr; 2001 Apr; 138(4):553-9. PubMed ID: 11295720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
    Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
    Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive tension time index in relation to severity of disease in children with cystic fibrosis.
    Hahn A; Ankermann T; Claass A; Mann M; Lindemann H; Neubauer BA
    Pediatr Pulmonol; 2008 Oct; 43(10):973-81. PubMed ID: 18780334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cystic fibrosis mutation associated with mild lung disease.
    Gan KH; Veeze HJ; van den Ouweland AM; Halley DJ; Scheffer H; van der Hout A; Overbeek SE; de Jongste JC; Bakker W; Heijerman HG
    N Engl J Med; 1995 Jul; 333(2):95-9. PubMed ID: 7539891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of breast-feeding practices and outcomes in the cystic fibrosis population.
    Parker EM; O'Sullivan BP; Shea JC; Regan MM; Freedman SD
    Pediatr Pulmonol; 2004 Apr; 37(4):362-7. PubMed ID: 15022134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise and sport in cystic fibrosis: benefits and risks.
    Webb AK; Dodd ME
    Br J Sports Med; 1999 Apr; 33(2):77-8. PubMed ID: 10205686
    [No Abstract]   [Full Text] [Related]  

  • 11. Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic.
    Radhakrishnan DK; Corey M; Dell SD
    Arch Pediatr Adolesc Med; 2007 Jun; 161(6):603-6. PubMed ID: 17548767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing correlations between spirometry and Shwachman-Kulczycki score in children and adolescents.
    Assis I; Camargos PA; Reis FJ; Sulmonett N; Carneiro AP
    Pediatr Pulmonol; 2003 Oct; 36(4):305-9. PubMed ID: 12950043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic modifiers of lung disease in cystic fibrosis.
    Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
    N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.
    Schluchter MD; Konstan MW; Davis PB
    Stat Med; 2002 May; 21(9):1271-87. PubMed ID: 12111878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight and obesity in deltaF508 homozygous cystic fibrosis.
    Kastner-Cole D; Palmer CN; Ogston SA; Mehta A; Mukhopadhyay S
    J Pediatr; 2005 Sep; 147(3):402-4. PubMed ID: 16182686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis.
    Nazer D; Abdulhamid I; Thomas R; Pendleton S
    Pediatr Pulmonol; 2006 Aug; 41(8):744-9. PubMed ID: 16779852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis mutations in southern Sweden: relationship to clinical severity.
    Kornfält R; Andreasson B; Holmberg L
    Acta Paediatr; 1992 Mar; 81(3):262-3. PubMed ID: 1511203
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary exacerbations in cystic fibrosis and bronchiectasis.
    Elborn JS; Bell SC
    Thorax; 2007 Apr; 62(4):288-90. PubMed ID: 17387213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shwachman-Kulczycki score and resting energy expenditure in cystic fibrosis.
    Dorlöchter L; Helgheim V; Røksund OD; Rosendahl K; Fluge G
    J Cyst Fibros; 2003 Sep; 2(3):148-51. PubMed ID: 15463864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis disease-specific centiles in 2000 and 2005.
    Stanke F; Ballmann M; Tümmler B
    Am J Respir Crit Care Med; 2006 May; 173(9):1047; author reply 1047. PubMed ID: 16632637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.